BridgeMD
New treatment option for Hallux Valgus
Official title Evaluation of the Impact of Self-rehabilitation After Foot Surgery Via a Connected Application
ClinicalTrials.gov ID: NCT07653828
What this study is testing
- What it's testing
- Hallux valgus is the most common forefoot deformity and primarily affects women. Surgical treatment involves an osteotomy of the first metatarsal to reduce the M1-M2 angle.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Age \> 18 years and \< 85 years,
- Patient, male or female, undergoing surgery for unilateral and isolated Hallux valgus with procedure of the 1st ray,
- First-line surgery,
- Persistent mobility of the metatarsophalangeal joint of the hallux,
- Patient in possession of a smartphone or tablet,
You likely can't join if
- Patient not having a smartphone or tablet,
- Rheumatoid foot,
- Hallux rigidus/MTP1 osteoarthritis,
- Gestures on the lateral rays
- Surgical or traumatic history influencing MTP1 mobility.
- Minors
See the full eligibility criteria
- Age \> 18 years and \< 85 years,
- Patient, male or female, undergoing surgery for unilateral and isolated Hallux valgus with procedure of the 1st ray,
- First-line surgery,
- Persistent mobility of the metatarsophalangeal joint of the hallux,
- Patient in possession of a smartphone or tablet,
- Patient affiliated with or beneficiary of a social security scheme,
- Patient who has signed the free and informed consent.
- Patient not having a smartphone or tablet,
- Rheumatoid foot,
- Hallux rigidus/MTP1 osteoarthritis,
- Gestures on the lateral rays
- Surgical or traumatic history influencing MTP1 mobility.
- Minors
- Adults under guardianship, curatorship or other legal protection, deprived of liberty by judicial decision or administrative;
- Pregnant, breastfeeding or parturient woman; - Hospitalized without consent
The study team makes the final eligibility decision.
Where it's taking place
- Saint-Jean, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Saint-Jean, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.